Determination of minimally important difference (MID) of EQ5D VAS and respiratory function in patients underwent lung resection for lung cancer

Determination of minimally important difference (MID) of EQ5D VAS and respiratory function in patients underwent lung resection for lung cancer - Determination of MID of QOL and respiratory function in lung cancer surgery

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037864

Enrollment

250

Registered

2019-10-07

Start date

2019-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients who will undergo lung resection for lung cancer or who will undergo diagnostic surgery on suspicion of early lung cancer

Exclusion criteria

Exclusion criteria: 1)reading disability of Japanese, 2)severe visual disorder, 3)cognitive impairment or impairment of decision-making ability, 4)pathological diagnosis except for lung cancer, 5)in the following cases, this protocol will be terminated, i)postoperative relapse, ii)metachronous lung cancer, iii)multiple primary cancer of other organ requiring major surgery, iv)disease or injury deteriorating QOL significantly

Design outcomes

Primary

Measure	Time frame
MID of EQ5D VAS and respiratory function one year after lung resection.	—

Secondary

Measure	Time frame
MID of EORTC QLQ C30 GHS and 6MWT	—

Countries

Japan

Contacts

Public ContactHideo Ichimura

Hitachi Medical Education and Research Center, University of Tsukuba Department of Thoracic Surgery

ichimura@md.tsukuba.ac.jp+81-294-23-1111

Outcome results